PULMONARY FIBROSIS
Clinical trials for PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug maker tracks Long-Term safety in major lung scarring study
Disease control Not yet recruitingThis study aims to understand the long-term safety of the drug Admilparant in people with pulmonary fibrosis, a serious lung scarring disease. It will follow over 2,200 patients who have already taken the drug in previous clinical trials. The main goal is to monitor for any side …
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New scan could spot scarring earlier
Diagnosis Not yet recruitingThis study is testing a new type of PET scan that uses a special tracer (68Ga-1A12) to detect and monitor fibrosis, which is scarring in organs like the lungs. The goal is to see if this scan can spot active scarring earlier and more accurately than current methods, without needi…
Matched conditions: PULMONARY FIBROSIS
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
Early safety check for new lung drug combo
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new drug called HRS-9813 interacts with two existing pulmonary fibrosis medications (pirfenidone and nintedanib) in healthy volunteers. Researchers will measure how the drugs affect each other's levels in the body and monitor for si…
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC